[Gonadorelin analogs combined with anti-androgens in the treatment of bone metastasis from prostate cancer. Can their use induce osteoporosis?].
Simonin
R
R
Nicolino-Peltier
C
C
Gainlet
P
P
D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols; D001859:Bone Neoplasms / Q000556:secondary*; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects* / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced*; D011471:Prostatic Neoplasms
D000726:Androgen Antagonists; D007987:Gonadotropin-Releasing Hormone
Analogues de la gonadoréline associés aux anti-androgènes dans le traitement des métastases osseuses du cancer de la prostate. Leur utilisation peut-elle induire une ostéoporose?